A shadow market for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Experimental Drug Gaining Traction Via Social Media
Retatrutide, which remains in research studies, is being advertised by online personalities for its supposed fat-burning properties. Followers are encouraged to contact these accounts directly for source information, while also receiving promotional offers.
Active Trade on Social Networks
Separately, a robust market exists on messaging services, where groups with thousands of members share comparison photos, injection guides and claims of rapid UK delivery. Vendors market the substance there before directing customers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Experts Express Concerns
However, doctors and chemists have cautions that the sale of what is still an unapproved medication in the United Kingdom is worrisome and could result in individuals administering products of uncertain source.
Some professionals stated the demand for the experimental drug could be connected to the rising price of licensed weight loss products such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Several content creators try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate medicines, marketing, and consumer regulations, risking penalties, legal action or imprisonment.
Platform Reaction and Content Removal
Based on TikTok, the platform has taken down problematic content and prohibited related keywords and search suggestions. The organization said it was committed to keeping the platform secure and allocating resources in strengthening enforcement strategies.
Digital Marketplace Activities
Investigations also discovered groups with up to 9,000 members marketing the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with numerous of members, populated with photos of weight loss, positive testimonials and step-by-step instructions for mixing or administering at home.
Within minutes of entering one group, a vendor shared WhatsApp details, where most transactions occur. The vendor provided an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one asked about weight, health issues or past usage.
Item Information and Pricing
Inside these communities, messages show dark colored packages with Royal Mail stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give conflicting responses varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for the messaging service stated it actively moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting materials they can’t verify. Although the research behind retatrutide is sound, these digital products may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, patients are using online platforms. But fake injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.
Her staff has already encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may expose users to possibly serious health risks”.
